RBC Capital analyst Luca Issi maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) on April 3 and set a price target of $330.00. The company’s shares closed yesterday at $235.74.

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

China Pharma (CPHI) Holdings reported that it expects to implement a 1-for-10 reverse stock split on its common stock effective Tuesday, April 15, with trading to begin on a split-adjusted basis ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs. By Rebecca Robbins ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

In this incarnation, Roderick Usher (Bruce Greenwood) and his sister, Madeline Usher (Mary McDonnell), own a powerful pharmaceutical company, and they’ve passed on their ruthless streak to the ...

INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer ...

Healthcare & Pharmaceuticalscategory· April 7, 2025 Rhythm Pharma's drug for rare obesity meets late-stage trial goal Rhythm Pharmaceuticals said on Monday its drug Imcivree notably reduced ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent rights in ...